Margit Kunz – Chief Executive Director, AHK Debelux
Germany and Belgium have long held an important trading relationship, says Margit Kunz of AHK Debelux, the German chamber of commerce in Belgium and Luxembourg. She outlines some of the…
Address: Archimedesstraat 11 – B1000 Brussels,Belgium
Tel: +32 2 285 42 00
Web: http://www.apb.be/Content/Default.asp
The General Pharmaceutical Association (APB) is the umbrella federation of the Belgian associations of independent pharmacists. APB represents 90 percent of the pharmaceutical corps, which essentially covers the total of the corresponding independent pharmacists.
The activities of the APB includes the advocacy of its members as well as other forms of assistance and information to its members.
Under the control of the General Assembly shall determine the general policy of the Federal Council, which is followed by the Management Committee. This includes not only ‘contacts’ with the Federal Government, Regions, Communities and the official authorities, but also the representation in the lap of numerous committees both at regulatory level and in terms of the health of the drug delivery control.
The APB members provide services including legal assistance, social and economic information, scientific and pharmaceutical documentation, etc.
In addition, the Office for Drug Research (DGO) part of the APB. The core of this officially recognized and accredited laboratory analysis, monitoring and systematic, periodic rechecking of medicines and products with a quality label.
Germany and Belgium have long held an important trading relationship, says Margit Kunz of AHK Debelux, the German chamber of commerce in Belgium and Luxembourg. She outlines some of the…
Perhaps to the surprise of many, Belgium is the world’s second-largest producer of vaccines, behind only the US, and – capitalising on its years of experience in the field –…
Back home in Belgium after a stellar stint in Big Pharma, Dr Paul Stoffels is now looking to reshape the future of cancer care with the previously struggling biotech he…
Belgian healthcare performs strongly across most metrics and international comparisons, but – as elsewhere – there remains room for improvement in terms of integrating patient feedback and experience into the…
20-year Astellas veteran Mark Dekker – now back in his home country of the Netherlands and overseeing the Benelux cluster having primarily developed his career in emerging European markets –…
Marnix Denys of beMedTech – the Belgian association for the medical technology industry – outlines the agenda priorities for the organisation that he hopes will lead to a more value-driven…
RaDiOrg aims to support rare disease patients and patient organisations in Belgium, defend their interests, and raise awareness of what can be devastating and little-understood conditions. Director Eva Schoeters –…
The newly merged Port of Antwerp-Bruges is the world’s first GDP-compliant seaport. CCO Tom Hautekiet explains the significant role the Port is playing in global healthcare supply chains – leveraging…
Back home in Belgium after a stellar stint in Big Pharma, Dr Paul Stoffels* is now looking to reshape the future of cancer care with the biotech he helped co-found…
Univercells is a group of companies founded a decade ago based around the concept of revolutionizing the availability of biologics around the world through making essential medicines affordable to all,…
GSK has undergone a number of changes in recent years. After driving a major transformation that began in 2017 to strengthen its R&D performance, the British multinational suffered the impact…
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has elected a new president and vice presidents who have set out a key priority for their term: a series of…
See our Cookie Privacy Policy Here
